Latest available resultsQuarter ended June 30, 202610-Q · July 30, 2026
Filed with the SECDEXCOM INC
DXCMHealthcare
Next reportOctober 28, 2026Analyst forecast 0.685 $/share
Revenue
$1.31B
▲ +13.1% vs prior year% YoY
Net income
$249.10M
▲ +38.5% vs prior year% YoY
EPS
0.64$
▲ +42.2% vs prior year% YoY
Net margin
19.0%
▲ +3.5 percentage points vs prior year pp YoY
Revenue▲ +13.1 %
Margins (% of revenue)GrossOperatingNet
Net income▲ +38.5 %
EPS▲ +42.2 %
View financial tableQuarter ended June 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $1.31B | |
| Gross profit | $830.00M | 63.4 % |
| Operating income | $318.30M | 24.3 % |
| Net income | $249.10M | 19.0 % |
| R&D | $153.00M | 11.7 % |
| EPS (diluted) | 0.64 $ | |
| Balance sheet | ||
| Assets | $6.46B | |
| Liabilities | $3.83B | |
| Equity | $2.62B | |
| Cash | $1.10B | |
| Capital | ||
| Shares outstanding | 377.36M | as of 2026-07-23 |
| Public float | — | |